Most studies have reported that thrombocytopenia is associated with a high trough concentration of LZD, long course of LZD treatment, combined use of meropenem, low albumin level, low baseline of PLT, and renal insufficiency in the adult population (Chen et al., 2012; Giunio-Zorkin and Brown, 2019; Kim et al., 2019; Ogami et al., 2019). This evidence concerns the gene ALB and Thrombocytopenia.